Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1/2 3Phase 1 3Phase 3 2Phase 2/3 2Phase NA 1Phase 4 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 19Tumor-Agnostic 14Sarcoma 3Other hematologic neoplasm 3Myeloid 2Genitourinary 2CNS 2Thoracic 1Plasma cell 1Other solid neoplasm 1Lymphoid 1Classical hematology 1Breast 1

Conditions

Sarcoma, Ewing 2Wilms Tumor 1Rhabdomyosarcoma 1Neuroblastoma 1Neoplasms 1Hepatoblastoma 1Gastrointestinal Stromal Tumors 1

Interventions

Temozolomide 62Cyclophosphamide 60Radiotherapy 48Doxorubicin 36Filgrastim 26Radiation 24Irinotecan 24fludarabine 23Gemcitabine 23Magnetic Resonance Spectroscopy 21Imatinib Mesylate 19Etoposide 18pembrolizumab 16Cisplatin 15Carboplatin 15Biopsy 15Bevacizumab 15Specimen Handling 14fludarabine phosphate 12Nivolumab 12Leucovorin 12Ipilimumab 12Granulocyte Colony-Stimulating Factor 12Chemotherapy, Adjuvant 12pazopanib 11Vincristine 11Ifosfamide 11Melphalan 10Erlotinib Hydrochloride 10Docetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × regorafenib × Sarcoma × Clear all
NCT05830084 2026-01-06

REGO-INTER-EWI

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Active not recruiting
23 enrolled
Sarcoma

Sarcoma, Ewing

NCT02085148 2024-04-22

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Bayer

Phase 1 Completed
62 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma

NCT02164240 2021-06-14

SURE

Dana-Farber Cancer Institute

Phase 1 Completed
14 enrolled 8 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡